Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Last 3 quarters through Sep 30, 2026 (filing window open)
Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory
records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book.
The quarter selector does not change this card.
Jun 30, 2026, the newest closed quarter:
39 filers,
like-for-like change +33.2%; actively managed books +33.2%.
Holder type
Share
Filers
Change
New
Exited
Registered adviser
68.4%
26
+23.5%
7
1
Exempt adviser
1.0%
1
0.0%
0
0
Adviser
10.8%
1
-0.6%
0
0
Bank
2.7%
1
+37.1%
0
0
Non-US
11.2%
4
+290.5%
3
0
Unknown
5.9%
6
+98.4%
4
1
Style
Share
Filers
Change
New
Exited
Systematic-like
16.4%
5
+133.1%
2
0
Concentrated
13.4%
4
+40.8%
1
1
Diversified active
70.2%
30
+19.9%
11
1
Turnover
Share
Filers
Change
New
Exited
Low turnover
0.4%
1
new
1
0
Medium turnover
55.8%
19
+22.2%
5
1
High turnover
43.5%
18
+49.4%
8
1
Unknown
0.3%
1
-13.1%
0
0
Holding horizon
Share
Filers
Change
New
Exited
Short horizon
47.2%
19
+32.6%
6
1
Medium horizon
6.6%
2
+8.2%
1
0
Long horizon
20.9%
8
-0.9%
3
1
Unknown
25.3%
10
+105.4%
4
0
13F book size
Share
Filers
Change
New
Exited
Under $1B
14.5%
10
+31.3%
4
1
$1B to $10B
53.1%
17
+34.9%
5
1
$10B to $100B
28.7%
10
+28.5%
4
0
$100B or more
3.8%
2
+55.6%
1
0
Client base
Share
Filers
Change
New
Exited
Pooled investment vehicles
67.7%
24
+23.0%
5
0
Charitable organizations
0.4%
1
new
1
0
Other investment advisers
0.3%
1
new
1
0
Individuals and high net worth
0.0%
0
-100.0%
0
1
Unknown
31.6%
13
+60.5%
7
1
Private funds
Share
Filers
Change
New
Exited
Hedge funds
68.6%
25
+22.7%
6
1
Private equity funds
0.3%
1
new
1
0
Other private funds
0.5%
1
0.0%
0
0
Unknown
30.6%
12
+63.8%
7
1
Location
Share
Filers
Change
New
Exited
United States
80.6%
32
+23.8%
11
2
Outside the US
19.4%
7
+94.4%
3
0
The Sep 30, 2026 filing window is still open, so its
bar shows only the filers that have filed so far.
How the mix is measured
Shares are 13F common shares restated to today's split basis; options and principal amounts are left out.
The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later
quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type
comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster
current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and
book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none
was. Actively managed books are those measured systematic-like, concentrated or diversified active.
Conviction and Crowding
39 13F filers, quarter ended Jun 30, 2026
Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts
filers with high turnover or that advise private funds on Form ADV.
Conviction holders
1
2.56% of filers hold it in their top 10
Mar 31, 2026: 1
Holders above 5%
0
median weight —
Mar 31, 2026: 0
Crowding
—
shares outstanding is an issuer-wide count, not one listing's
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
shares outstanding is an issuer-wide count, not one listing's
Top 10 holders
54.9%
of 13F shares, Herfindahl 0.045
Active holders
+33.2%
like-for-like share change of active filers
5% stakes on record
0
0 13D, 0 13G
Managers in the top fifth by current three-year FundScore alpha were net
buyers of $0
(0 buying, 0 selling).
Shared Holders
Companies KRAQW's active holders also own, quarter ended Jun 30, 2026
New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.
